APA način citiranja

Tsuboi, K., & Yamamoto, H. (2012). Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal). Nature Publishing Group.

Čikaški stil citiranja

Tsuboi, Kazuya, i Hiroshi Yamamoto. Clinical Observation of Patients With Fabry Disease After Switching From Agalsidase Beta (Fabrazyme) to Agalsidase Alfa (Replagal). Nature Publishing Group, 2012.

MLA način citiranja

Tsuboi, Kazuya, i Hiroshi Yamamoto. Clinical Observation of Patients With Fabry Disease After Switching From Agalsidase Beta (Fabrazyme) to Agalsidase Alfa (Replagal). Nature Publishing Group, 2012.